BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18467244)

  • 1. Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.
    Debbia EA; Maioli E; Roveta S; Marchese A
    J Chemother; 2008 Apr; 20(2):186-94. PubMed ID: 18467244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.
    Ricci A; Coppo E; Barbieri R; Debbia EA; Marchese A
    J Chemother; 2017 Apr; 29(2):67-73. PubMed ID: 27285830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth.
    Pistiki A; Galani I; Pyleris E; Barbatzas C; Pimentel M; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2014 Mar; 43(3):236-41. PubMed ID: 24461710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rifaximin on gut flora and Staphylococcus resistance.
    Kim MS; Morales W; Hani AA; Kim S; Kim G; Weitsman S; Chang C; Pimentel M
    Dig Dis Sci; 2013 Jun; 58(6):1676-82. PubMed ID: 23589147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability.
    Ruiz J; Mensa L; Pons MJ; Vila J; Gascon J
    J Antimicrob Chemother; 2008 May; 61(5):1016-9. PubMed ID: 18325895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conjugative transfer frequency of resistance genes from ESBL-producing Enterobacteriaceae strains isolated from patients hospitalized in pediatric wards].
    Franiczek R; Dolna I; Krzyzanowska B; Szufnarowski K; Kowalska-Krochmal B; Zielińska M
    Med Dosw Mikrobiol; 2006; 58(1):41-51. PubMed ID: 16871972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
    Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
    J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial susceptibility of enterobacteriaceae isolated from raw horsemeat isolated for human consumption (basashi).
    Furuhata K; Ishizaki N; Fukuyama M
    Biocontrol Sci; 2015; 20(1):19-25. PubMed ID: 25817809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
    Alhambra A; Cuadros JA; Cacho J; Gómez-Garcés JL; Alós JI
    J Antimicrob Chemother; 2004 Jun; 53(6):1090-4. PubMed ID: 15117925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
    Bayraktar B; Toksoy B; Bulut E
    Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.
    Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S
    Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
    Hoover WW; Gerlach EH; Hoban DJ; Eliopoulos GM; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1993 Feb; 16(2):111-8. PubMed ID: 8385592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.
    Scarpignato C; Pelosini I
    Chemotherapy; 2005; 51 Suppl 1():36-66. PubMed ID: 15855748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
    Yang H; Chen H; Yang Q; Chen M; Wang H
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4268-73. PubMed ID: 18809939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.